Abstract:BACKGROUND: Intensive care unit (ICU) patients are critically ill and have low immunity. They will undergo various trauma medical procedures during diagnosis and treatment. The use of high-dose hormones and broad-spectrum antibiotics will increase the incidence of nosocomial infection in ICU patients. Therefore, it is necessary to explore the causes of nosocomial infection in ICU and provide basis for the prevention and control of nosocomial infection in ICU.AIM: To explore major pathogens of nosocomial infection in ICUs, methods of detection and drug resistance trends.METHODS: Risk factors of multidrug-resistant infection were analyzed to provide a basis for clinical rational use of antimicrobial drugs in the ICU. These findings were used to standardize rational use of antimicrobial agents. BD PhoenixTM100 automatic bacterial identification analyzer was used to for cell identification in specimens collected from the ICU between January 2016 and December 2019. Drug sensitivity tests were carried out and drug resistance trends were analyzed using the optical disc diffusion method. Odds ratios and corresponding 95%CI of independent variables were calculated using a logistic regression model. Backward elimination (trend = 0.1) was used as an inclusion criterion for multivariate analysis. All data were analyzed using SPSS version 22.0, and P < 0.05 was considered statistically significant.RESULTS: We collected 2070 samples from ICU patients between January 2016 and December 2019. Sample types comprised sputum (1139 strains, 55.02%), blood (521 strains, 25.17%), and drainage fluid (117 strains, 5.65%). A total of 1051 strains of major pathogens, including Acinetobacter baumannii, Escherichia coli (E. coli), Pseudomonas aeruginosa (P. aeruginosa), Klebsiella pneumoniae (K. pneumoniae) and Staphylococcus aureus, were detected, with a detection rate of 35.97% (378/1051). Most of these strains were resistant to antibiotics. Detection rate of E. coli was 21.79% (229/1051), and it was generally sensitive to many antimicrobial drugs. Detection rate of P. aeruginosa was 24.74% (260/1051), and showed low sensitivity to most antibiotics. Detection rate of K. pneumoniae was 9.42% (99/1051), which was generally resistant to multiple antimicrobial drugs and resistant forms. K. pneumoniae was resistant to imipenem for approximate 4 years, and showed a 19.9% (19/99) and 20.20% (20/99) rate of meropenem resistance. Logistic analysis showed that mechanical ventilation and ureteral intubation were risk factors for multidrug-resistant bacterial infections.CONCLUSION: This study showed a high incidence of ICU infections. Mechanical ventilation and urine tube intubation were risk factors for infection with multidrug-resistant bacteria.

Role of nursing risk warning system in prevention of multidrug-resistant bacteria infections in ICU patients

Countermeasures of Improving the Prevention and Control of MDRO Infection in Primary Hospitals

Risk factors and nursing strategies of nosocomial infection in patients with coronary heart disease in hospital

Preemptive Isolation And Active Surveillance In The Prevention And Control Of Nosocomial Infection Reduce The Incidence Of Carbapenem-Resistant Enterobacteriaceae

Multidrug-resistant organisms in intensive care units and logistic analysis of risk factors

Strengthening control and management of multidrug-resistant bacteria to prevent hospital infection outbreaks

Development of healthcare-associated infection risk management and early-warning system based on failure mode and effect analysis model

Mohnarin Report of 2011: Monitoring of Bcterial Resistance Intensive Care Unit

Risk factors for nosocomial infections in RICU and nursing interventions

Effect of an Inpatient Nursing Risk Early Warning and Control System in Shanghai: A Retrospective Study of Adverse Events

Mohnarin Report of 2010 :Surveillance of Bacterial Resistance of Non-Icu Inpatients

Mohnarin Report of 2010:Monitoring of Bacterial Resistance in Intensive Care Units

Mohnarin report of 2011:monitoring of bacterial resistance of non-ICU inpatients

Use of antibiotics in multi-center ICU and surveillance of multidrug-resistant organisms in China

Active surveillance of multidrug-resistant organisms in SICU in a general hospital in 2008 and 2011

Multicenter study on effectiveness of intervention in multidrug-resistant organism infection

Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria

How to Defeat Multidrug-Resistant Bacteria in Intensive Care Units. A Lesson from the COVID-19 Pandemic. Prevention, Reservoirs, and Implications for Clinical Practice

121 Drug-Resistance Analysis and Prevention of MRSA in Nenrosurgery Intensive Care Unit

First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs

Monitoring and Control of Pan-Drug Resistant Acinetobacter Baumannii Colonization and Infection in a Medical Intensive Care Unit